Arian Eghbali, who founded a company called Goldman Sachs Capital LLC that is unaffiliated with the investment bank, has ...

Goldman Sachs has added these three stocks to its Conviction List. They all have at least 20% upside potential to the analyst ...

Investors, analysts, members of the media and the general public are invited to listen to a live audio webcast of the presentation at this weblink.

In addition to sickle cell disease, rilzabrutinib has received orphan drug designation for immune thrombocytopenia (ITP) in the US, the EU, and Japan, for warm autoimmune hemolytic anemia (wAIHA) in ...